ID   CIP1_HUMAN              Reviewed;         277 AA.
AC   Q9NPC3;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   12-APR-2017, entry version 145.
DE   RecName: Full=E3 ubiquitin-protein ligase CCNB1IP1;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:12612082};
DE   AltName: Full=Cyclin-B1-interacting protein 1;
DE   AltName: Full=Human enhancer of invasion 10;
DE   AltName: Full=RING-type E3 ubiquitin transferase CCNB1IP1 {ECO:0000305};
GN   Name=CCNB1IP1; Synonyms=C14orf18, HEI10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS OF CYS-28; HIS-30 AND CYS-33,
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH UBE2L3 AND CCNB1,
RP   UBIQUITINATION, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12612082; DOI=10.1128/MCB.23.6.2109-2122.2003;
RA   Toby G.G., Gherraby W., Coleman T.R., Golemis E.A.;
RT   "A novel RING finger protein, human enhancer of invasion 10, alters
RT   mitotic progression through regulation of cyclin B levels.";
RL   Mol. Cell. Biol. 23:2109-2122(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal brain, and Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH NF2.
RX   PubMed=16532029; DOI=10.1038/sj.onc.1209475;
RA   Gronholm M., Muranen T., Toby G.G., Utermark T., Hanemann C.O.,
RA   Golemis E.A., Carpen O.;
RT   "A functional association between merlin and HEI10, a cell cycle
RT   regulator.";
RL   Oncogene 25:4389-4398(2006).
RN   [7]
RP   FUNCTION.
RX   PubMed=17297447; DOI=10.1038/sj.onc.1210282;
RA   Singh M.K., Nicolas E., Gherraby W., Dadke D., Lessin S.,
RA   Golemis E.A.;
RT   "HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1
RT   and other promotility proteins.";
RL   Oncogene 26:4825-4832(2007).
CC   -!- FUNCTION: Ubiquitin E3 ligase that acts as a limiting factor for
CC       crossing-over during meiosis: required during zygonema to limit
CC       the colocalization of RNF212 with MutS-gamma-associated
CC       recombination sites and thereby establish early differentiation of
CC       crossover and non-crossover sites. Later, it is directed by MutL-
CC       gamma to stably accumulate at designated crossover sites. Probably
CC       promotes the dissociation of RNF212 and MutS-gamma to allow the
CC       progression of recombination and the implementation of the final
CC       steps of crossing over (By similarity). Modulates cyclin-B levels
CC       and participates in the regulation of cell cycle progression
CC       through the G2 phase. Overexpression causes delayed entry into
CC       mitosis. {ECO:0000250, ECO:0000269|PubMed:12612082,
CC       ECO:0000269|PubMed:17297447}.
CC   -!- FUNCTION: E3 ubiquitin-protein ligase. Modulates cyclin B levels
CC       and participates in the regulation of cell cycle progression
CC       through the G2 phase. Overexpression causes delayed entry into
CC       mitosis.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:12612082}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with CCNB1, UBE2L3 and NF2.
CC       {ECO:0000269|PubMed:12612082, ECO:0000269|PubMed:16532029}.
CC   -!- INTERACTION:
CC       P62972:- (xeno); NbExp=2; IntAct=EBI-745269, EBI-412964;
CC       P14635:CCNB1; NbExp=2; IntAct=EBI-745269, EBI-495332;
CC       Q7L775:EPM2AIP1; NbExp=3; IntAct=EBI-745269, EBI-6255981;
CC       Q14145:KEAP1; NbExp=3; IntAct=EBI-745269, EBI-751001;
CC       P19012:KRT15; NbExp=3; IntAct=EBI-745269, EBI-739566;
CC       P54646:PRKAA2; NbExp=3; IntAct=EBI-745269, EBI-1383852;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Associates to the
CC       synaptonemal complex.
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart. Detected at
CC       intermediate levels in liver and kidney, and at low levels in
CC       placenta, brain and lung. {ECO:0000269|PubMed:12612082}.
CC   -!- PTM: Ubiquitinated; autoubiquitinated.
CC       {ECO:0000269|PubMed:12612082}.
CC   -!- PTM: Phosphorylated by CDK1 on serine or threonine residues (in
CC       vitro). {ECO:0000269|PubMed:12612082}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF216381; AAF36386.1; -; mRNA.
DR   EMBL; AL161994; CAB82326.1; -; mRNA.
DR   EMBL; AK026233; BAB15403.1; -; mRNA.
DR   EMBL; BX161423; CAD61896.1; -; mRNA.
DR   EMBL; BX161424; CAD61897.1; -; mRNA.
DR   EMBL; BX247978; CAD62312.1; -; mRNA.
DR   EMBL; BC000369; AAH00369.1; -; mRNA.
DR   EMBL; BC001218; AAH01218.1; -; mRNA.
DR   EMBL; BC004435; AAH04435.1; -; mRNA.
DR   CCDS; CCDS9547.1; -.
DR   PIR; T47153; T47153.
DR   RefSeq; NP_067001.3; NM_021178.4.
DR   RefSeq; NP_878269.1; NM_182849.2.
DR   RefSeq; NP_878272.1; NM_182852.3.
DR   UniGene; Hs.107003; -.
DR   UniGene; Hs.741214; -.
DR   ProteinModelPortal; Q9NPC3; -.
DR   SMR; Q9NPC3; -.
DR   BioGrid; 121779; 12.
DR   IntAct; Q9NPC3; 11.
DR   MINT; MINT-1450464; -.
DR   STRING; 9606.ENSP00000337396; -.
DR   iPTMnet; Q9NPC3; -.
DR   PhosphoSitePlus; Q9NPC3; -.
DR   BioMuta; CCNB1IP1; -.
DR   DMDM; 37078756; -.
DR   PaxDb; Q9NPC3; -.
DR   PeptideAtlas; Q9NPC3; -.
DR   PRIDE; Q9NPC3; -.
DR   DNASU; 57820; -.
DR   Ensembl; ENST00000353689; ENSP00000337396; ENSG00000100814.
DR   Ensembl; ENST00000358932; ENSP00000351810; ENSG00000100814.
DR   Ensembl; ENST00000398160; ENSP00000381226; ENSG00000100814.
DR   Ensembl; ENST00000398163; ENSP00000381229; ENSG00000100814.
DR   Ensembl; ENST00000398169; ENSP00000381235; ENSG00000100814.
DR   Ensembl; ENST00000437553; ENSP00000409896; ENSG00000100814.
DR   GeneID; 57820; -.
DR   KEGG; hsa:57820; -.
DR   UCSC; uc001vwv.5; human.
DR   CTD; 57820; -.
DR   GeneCards; CCNB1IP1; -.
DR   HGNC; HGNC:19437; CCNB1IP1.
DR   MIM; 608249; gene.
DR   neXtProt; NX_Q9NPC3; -.
DR   OpenTargets; ENSG00000100814; -.
DR   PharmGKB; PA134863884; -.
DR   eggNOG; ENOG410IE9K; Eukaryota.
DR   eggNOG; ENOG410XTEP; LUCA.
DR   GeneTree; ENSGT00390000002849; -.
DR   HOGENOM; HOG000111677; -.
DR   HOVERGEN; HBG050962; -.
DR   InParanoid; Q9NPC3; -.
DR   KO; K10639; -.
DR   OMA; IANHEGT; -.
DR   OrthoDB; EOG091G0RN7; -.
DR   PhylomeDB; Q9NPC3; -.
DR   TreeFam; TF328863; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; CCNB1IP1; human.
DR   GeneWiki; CCNB1IP1; -.
DR   GenomeRNAi; 57820; -.
DR   PRO; PR:Q9NPC3; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100814; -.
DR   CleanEx; HS_CCNB1IP1; -.
DR   ExpressionAtlas; Q9NPC3; baseline and differential.
DR   Genevisible; Q9NPC3; HS.
DR   GO; GO:0000795; C:synaptonemal complex; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0001825; P:blastocyst formation; IEA:Ensembl.
DR   GO; GO:0051026; P:chiasma assembly; ISS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0007131; P:reciprocal meiotic recombination; ISS:UniProtKB.
DR   GO; GO:0007286; P:spermatid development; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF14634; zf-RING_5; 1.
PE   1: Evidence at protein level;
KW   Chromosome; Coiled coil; Complete proteome; Meiosis; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    277       E3 ubiquitin-protein ligase CCNB1IP1.
FT                                /FTId=PRO_0000055874.
FT   ZN_FING       4     51       RING-type; atypical.
FT   COILED      127    182       {ECO:0000255}.
FT   MUTAGEN      28     28       C->A: Abrogates induction of filamentous
FT                                growth in yeast; when associated with A-
FT                                30 and A-33.
FT                                {ECO:0000269|PubMed:12612082}.
FT   MUTAGEN      30     30       H->A: Abrogates induction of filamentous
FT                                growth in yeast; when associated with A-
FT                                28 and A-33.
FT                                {ECO:0000269|PubMed:12612082}.
FT   MUTAGEN      33     33       C->A: Abrogates induction of filamentous
FT                                growth in yeast; when associated with A-
FT                                28 and A-30.
FT                                {ECO:0000269|PubMed:12612082}.
SQ   SEQUENCE   277 AA;  31544 MW;  885723B01A35225A CRC64;
     MSLCEDMLLC NYRKCRIKLS GYAWVTACSH IFCDQHGSGE FSRSPAICPA CNSTLSGKLD
     IVRTELSPSE EYKAMVLAGL RPEIVLDISS RALAFWTYQV HQERLYQEYN FSKAEGHLKQ
     MEKIYTQQIQ SKDVELTSMK GEVTSMKKVL EEYKKKFSDI SEKLMERNRQ YQKLQGLYDS
     LRLRNITIAN HEGTLEPSMI AQSGVLGFPL GNNSKFPLDN TPVRNRGDGD GDFQFRPFFA
     GSPTAPEPSN SFFSFVSPSR ELEQQQVSSR AFKVKRI
//
